Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Leukemia 41Myelodysplastic Syndromes 35Lymphoma, Non-Hodgkin 17Recurrence 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Lymphocytic, Chronic, B-Cell 11Hodgkin Disease 11Congenital Abnormalities 11Lymphoma 10Leukemia, Myelomonocytic, Chronic 10Hematologic Neoplasms 8Leukemia, Biphenotypic, Acute 7Neoplasms 6Multiple Myeloma 6Leukemia, Myelomonocytic, Juvenile 6Burkitt Lymphoma 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Graft vs Host Disease 5Anemia, Refractory, with Excess of Blasts 5Lymphoma, Mantle-Cell 4Lymphoma, B-Cell 4Leukemia, Promyelocytic, Acute 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Eosinophilic, Acute 4

Interventions

selinexor 1pegfilgrastim 1midostaurin 1Topotecan 1Rituximab 1Prednisone 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Methylprednisolone 1Immunologic Techniques 1Ifosfamide 1Flow Cytometry 1Etoposide 1Dexamethasone 1Clofarabine 1Carboplatin 1Bexarotene 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Aggression × Clofarabine × Clear all
NCT00201669 2017-12-06

A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
6 enrolled
Lymphoid

Aggression, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡